DK1049468T3 - Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår - Google Patents

Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår

Info

Publication number
DK1049468T3
DK1049468T3 DK99902528T DK99902528T DK1049468T3 DK 1049468 T3 DK1049468 T3 DK 1049468T3 DK 99902528 T DK99902528 T DK 99902528T DK 99902528 T DK99902528 T DK 99902528T DK 1049468 T3 DK1049468 T3 DK 1049468T3
Authority
DK
Denmark
Prior art keywords
hydroxypyridone
tibia
treatment
containing powder
pressure ulcers
Prior art date
Application number
DK99902528T
Other languages
Danish (da)
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1049468T3 publication Critical patent/DK1049468T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK99902528T 1998-01-24 1999-01-11 Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår DK1049468T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
PCT/EP1999/000105 WO1999037300A1 (de) 1998-01-24 1999-01-11 Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren

Publications (1)

Publication Number Publication Date
DK1049468T3 true DK1049468T3 (da) 2007-07-30

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902528T DK1049468T3 (da) 1998-01-24 1999-01-11 Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår

Country Status (27)

Country Link
US (1) US6534528B1 (enExample)
EP (1) EP1049468B1 (enExample)
JP (1) JP5127091B2 (enExample)
KR (1) KR100597332B1 (enExample)
CN (1) CN1128619C (enExample)
AR (1) AR016445A1 (enExample)
AT (1) ATE360418T1 (enExample)
AU (1) AU752406B2 (enExample)
BR (1) BR9907734A (enExample)
CA (1) CA2319359C (enExample)
CY (1) CY1106684T1 (enExample)
DE (2) DE19802708A1 (enExample)
DK (1) DK1049468T3 (enExample)
ES (1) ES2285829T3 (enExample)
HR (1) HRP20000496A2 (enExample)
HU (1) HU228824B1 (enExample)
IL (1) IL137453A (enExample)
ME (1) MEP55908A (enExample)
NZ (1) NZ505898A (enExample)
PL (1) PL192550B1 (enExample)
PT (1) PT1049468E (enExample)
RS (1) RS50903B (enExample)
RU (1) RU2212239C2 (enExample)
SI (1) SI1049468T1 (enExample)
SK (1) SK285350B6 (enExample)
TR (1) TR200002118T2 (enExample)
WO (1) WO1999037300A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
ES2525387T3 (es) * 2010-07-27 2014-12-23 Clariant Finance (Bvi) Limited Composiciones que contienen peróxido de hidrógeno o sustancias que ponen en libertad peróxido de hidrógeno
BR112013001953A2 (pt) * 2010-07-27 2018-05-15 Clariant Finance Bvi Ltd uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio
RS61907B1 (sr) 2015-04-06 2021-06-30 Subdomain Llc Polipeptidi koji sadrže de novo vezujući domen i njihova primena

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
AR242187A1 (es) * 1986-04-18 1993-03-31 Hoechst Ag Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
PT865278E (pt) * 1995-12-04 2002-10-31 Aventis Pharma Gmbh Utilizacao de 1-hidroxi-2-piridonas para o tratamento de doencas terapeuticamente dificeis de mucosidade da pele

Also Published As

Publication number Publication date
HUP0200851A1 (hu) 2002-07-29
HRP20000496A2 (en) 2000-12-31
DE19802708A1 (de) 1999-07-29
TR200002118T2 (tr) 2000-12-21
YU43700A (sh) 2003-08-29
PL192550B1 (pl) 2006-11-30
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29
AU752406B2 (en) 2002-09-19
CA2319359A1 (en) 1999-07-29
AR016445A1 (es) 2001-07-04
SK285350B6 (sk) 2006-11-03
JP2002501020A (ja) 2002-01-15
US6534528B1 (en) 2003-03-18
EP1049468B1 (de) 2007-04-25
AU2278799A (en) 1999-08-09
ATE360418T1 (de) 2007-05-15
IL137453A (en) 2005-11-20
EP1049468A1 (de) 2000-11-08
HU228824B1 (en) 2013-05-28
NZ505898A (en) 2002-06-28
PL342055A1 (en) 2001-05-21
BR9907734A (pt) 2000-10-17
MEP55908A (en) 2011-05-10
SI1049468T1 (sl) 2007-08-31
PT1049468E (pt) 2007-05-31
CA2319359C (en) 2008-03-18
CY1106684T1 (el) 2012-05-23
KR20010034325A (ko) 2001-04-25
IL137453A0 (en) 2001-07-24
ES2285829T3 (es) 2007-11-16
DE59914312D1 (de) 2007-06-06
SK10892000A3 (sk) 2000-12-11
HUP0200851A3 (en) 2003-05-28
CN1128619C (zh) 2003-11-26
CN1288380A (zh) 2001-03-21
RS50903B (sr) 2010-08-31
KR100597332B1 (ko) 2006-07-10
JP5127091B2 (ja) 2013-01-23
RU2212239C2 (ru) 2003-09-20
HK1034447A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
EP1283702A4 (en) MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
PL332934A1 (en) The use of nano-dispersion for final cosmetic preparations
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
IT1296619B1 (it) Procedimento per il trattamento di protesi a struttura aperturata e relativi dispositivi.
DK114997A (da) Mundhygejnepræparat til behandling af halitosis
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
DE69526237D1 (de) Chirurgische gesichtsmaske
NO984094L (no) Utladningsreaktor og anvendelse av samme
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO993066D0 (no) Ny behandling for leddinflammasjon
DK199800837A (da) Anlæg til behandling af emner
FI965204A0 (fi) Bromelaiinin lääkekäyttö
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DK1049468T3 (da) Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår
ATE298576T1 (de) Arzneizubereitungen
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
DE69830259D1 (de) Gewebeschutzmittel und der Gebrauch desselben
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (en) Medicinal preparations
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö